Resources:

Find resources by:

Sort by:

Date Resource A-Z Random

Resources from the last:

Box size:

Filer text box:

Topic familiarity:

Grid Layout:

Collections that use this topic:

Collection topics:

Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

Resource Hub Endocrine Cancer including late effects

Adrenal & Cardiovascular Bone & Calcium Diabetes Endocrine Cancer including late effects Endocrine disruptors Metabolism Neuroendocrinology Obesity Paediatric Pituitary Reproductive Thyroid Parathyroid Hyperparathyroidism Hypercalcaemia Parathyroid Hormone-PTH Diabetes Insipidus Health Equity Virtual Care Patient-Initiated Follow up Job planning Clinical Pathway Referral guides Trainee resources Patient safety Patient Information Sheets Student Early Career Nurse Secondary care Clinical academic career Clinical research Clinical practice career Careers Working in clinical research

Resource not read: Query You and Your Hormones

14.11. Effect of thyroid hormone and growth hormone on recovery from hypothyroidism of epiphyseal growth plate cartilage and its adjacent bone

Late effects of allogeneic stem cell transplants on the endocrine and metabolic systems

7.8. Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study

Endocrinal Disorders in Patients with Chronic Lung Diseases, Single-Center Experience

Adrenocortical carcinoma: single center experience

The Inflammasome molecular machinery as a novel source of diagnostic, prognostic, and therapeutic targets in endocrine-related cancers

Joining forces in endocrine cancer genetics

Novel driver mutations in thyroid cancer recurrence

Novel driver mutations in thyroid cancer recurrence

Different Endocrine Affects in DICER-1 Syndrome

Defining the clinical value of MYD88, a component of the inflammasome machinery, as a diagnosis, prognosis and therapeutic tool in brain endocrine cancers

Living with and beyond childhood cancer  endocrine impact up to 40 years on

Endocrine complications after childhood cancer

Post-COVID-19 male hypogonadism: an area of endocrine concern?

Effects of sugar cane extract (SCE) supplementation on steroidogenesis of the adrenal cortex in male rats

Two case reports of preserved endocrine and exocrine function in VHL patients with extensive pancreatic cysts

Care of cancer survivors: the role of endocrinologists

7.15. Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER): a cross-sectional study

Multiple endocrinal disorders & nephrotic syndrome in a patient with covert lung cancer

It’s not "all too hard"! Together we CAN improve access to essential paediatric endocrine medicines for all. A roadmap to 2030.

Do immune checkpoint inhibitor-related endocrinopathies affect survival rates in cancer patients? Presentation of two case reports

Population remodeling in the acquisition of endocrine resistance in breast cancer

Population remodeling in the acquisition of endocrine resistance in breast cancer

Choosing the right sex steroid replacement option for patients: the role of the endocrine nurse

9.1. Premature ovarian insufficiency and chance of pregnancy after childhood cancer: a population-based study (the Fex-Can study)

Cancer Survivors-the New Endocrine Epidemic

Cancer Survivors-the New Endocrine Epidemic

Effects of antiandrogen therapy of cyproteron acetate on androgen effects on the skin including androgenetic alopecia in menopausal women - case report: 10 years follow up -

Late night salivary cortisol measurement may help in excluding Cushings syndrome in patients with chronic kidney disease

Including psychological variables in health economic modelling of obesity

Development of IT based nurse led endocrine tracking system

Extracellular-vesicles from the peri-prostatic adipose tissue of obese, but not lean, men promote prostate cancer aggressivity

Thyroid cancer and endocrine disruptive chemicals: a case-control study on per-fluoroalkyl substances (PFAS)

Prevalance of cancer in acromegaly patients; a single center data

7.14. Hypothalamic-pituitary and other endocrine surveillance among childhood cancer survivors

SF3B1 as novel target for the treatment of multiple endocrine-related cancers

Hypoglycaemia in non-diabetic children  data from a paediatric endocrine center

ER status heterogeneity in breast cancer: role in response to endocrine treatment

A cell-based platform to screen chemical mixtures for endocrine disruptive effects

Biochemical analysis of radioiodine uptake enhancement in endocrine cancer

Adolescent body mass index and osteoporosis risk: a nationwide study of one million israeli adolescents

6.5 Statement on gender-affirmative approach to care from the pediatric endocrine society special interest group on transgender health

A rare endocrine complication of immunotherapy in lung cancer

Environmental endocrine disruptors and testicular germ cell cancer

Exploring the potential benefit of epigenetic modification: The LANTana trial, an open label, single arm, phase Ib study to evaluate the effect of pre-treatment with ASTX727 (a demethylating agent) followed by Lutathera (<sup>177</sup>Lu-DOTATATE) in patients with progressive, metastatic neuroendocrine tumours (NETs)

Quantitative image based analysis of endocrine disruptor effects on mitochondria morphology-function in prostate cancer cells

Controlled Antenatal Thyroid Screening (CATS) II: long-term cardiometabolic effects of treating maternal sub-optimal thyroid function

An unusual case of Gynaecomastia from hCG secreting bladder cancer

An unusual case of Gynaecomastia from hCG secreting bladder cancer

A large series of patients with anaplastic thyroid cancer managed in a tertiary referral center